Similar Items: Consistency of response to rimegepant for the acute treatment of migraine among real-world users – findings from the prospective observational CONFIDENCE study
- Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: a Korean multicenter study
- CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhage
- Clinical and social burden of migraine in Japanese males: a cross-sectional comparison with females without menstrual migraine
- Migraine impairs the auditory protective mechanism: a potential biomarker
- From bench to bedside: relevant animal models across the migraine attack phases
- Migraine and menopause as converging factors in brain vulnerability: a hypothesis-driven perspective